There should be no result in clinically significant significant foetal/neonatal haemolysis, severe change to the published foetal/neonatal haemolysis, severe anaemia and hyperbilirubinaemia. text anaemia and hyperbilirubinaemia. Justification for Although prophylaxis programs Although prophylaxis programs have reduced the SWG have suggested updating Evidence have reduced the frequency of frequency of Rhesus (Rh) D HDN, antibodies to with the addition of Category Rhesus (Rh) D HDN, antibodies to RhD remain the most common cause in Australia. recommendation 7 from the There should be no RhD remain the most common Antibodies to other antigens in the Rh system Patient Blood management change to the published cause in Australia. Antibodies to (e.g. Rhc, E), ABO and other antigens (e.g. K) may guideline – module 7 – text other antigens in the Rh system also cause disease ranging from mild to life - paediatric and neonatal. (e.g. Rhc, E), ABO and other antigens (e.g. K) may also cause disease ranging from mild to Diagnosis is By which required speciality Diagnosis must be By which verified speciality Exclusion Criteria Bullet list of exclusion criteria Indications Qualifying Criteria IVIg may be used in selected cases IVIg may be used in selected cases in consultation Spelling correction to in consultation with experts in with experts in fetomaternal medicine and fetomaternal. foetomaternal medicine and transfusion medicine. Addition of Expert opinion
There should be no change to the published text result in clinically significant foetal/neonatal haemolysis, severe anaemia and hyperbilirubinaemia. significant foetal/neonatal haemolysis, severe anaemia and hyperbilirubinaemia. Justification for Evidence Category There should be no change to the published text Although prophylaxis programs have reduced the frequency of Rhesus (Rh) D HDN, antibodies to RhD remain the most common cause in Australia. Antibodies to other antigens in the Rh system (e.g. Rhc, E), ABO and other antigens (e.g. K) may also cause disease ranging from mild to Although prophylaxis programs have reduced the frequency of Rhesus (Rh) D HDN, antibodies to RhD remain the most common cause in Australia. Antibodies to other antigens in the Rh system (e.g. Rhc, E), ABO and other antigens (e.g. K) may also cause disease ranging from mild to life SWG have suggested updating with the addition of recommendation 7 from the Patient Blood management guideline – module 7 – paediatric and neonatal. Diagnosis is required By which speciality Diagnosis must be verified By which speciality Exclusion Criteria Bullet list of exclusion criteria Indications Qualifying Criteria IVIg may be used in selected cases in consultation with experts in foetomaternal medicine and IVIg may be used in selected cases in consultation with experts in fetomaternal medicine and transfusion medicine. Spelling correction to fetomaternal. Addition of Expert opinion -